Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers as antiarrhythmic agents.

S Zicha1, Y Tsuji, A Shiroshita-Takeshita

  • 1Montreal Heart Institute, 5000 Belanger East, Montreal Quebec, HIT 1C8, Canada. stanley.nattel@icm-mhi.org

Handbook of Experimental Pharmacology
|April 14, 2006
PubMed
Summary

Beta-blockers prevent arrhythmias by blocking beta-adrenergic signaling, not by directly altering ion channels. They are crucial for preventing sudden cardiac death and managing conditions like atrial fibrillation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila.

Scientific reports·2018
Same author

Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing.

Progress in biophysics and molecular biology·2011
Same author

The Treatment of PVCs and Prevention of Sudden Cardiac Death: New findings from the CAST study.

Canadian family physician Medecin de famille canadien·2011
Same author

Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes.

British journal of pharmacology·2007
Same author

Atrial cell action potential parameter fitting using genetic algorithms.

Medical & biological engineering & computing·2006
Same author

Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2005

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-adrenergic signaling significantly influences cardiac function and can promote arrhythmias.
  • Existing antiarrhythmic drugs often target ion channels directly.
  • Beta-blockers offer a distinct mechanism by inhibiting beta-adrenergic stimulation.

Purpose of the Study:

  • To review the antiarrhythmic properties of beta-blockers.
  • To elucidate the mechanisms by which beta-blockers prevent cardiac arrhythmias.
  • To discuss the clinical applications and differentiating properties of various beta-blocker agents.

Main Methods:

  • Review of beta-adrenoceptor signaling pathways.
  • Analysis of cardiac arrhythmia mechanisms.
  • Examination of ion channel involvement in beta-adrenergic responses.

Related Experiment Videos

  • Synthesis of clinical evidence for beta-blocker therapy.
  • Comparison of pharmacodynamic and pharmacokinetic profiles of beta-blockers.

    • Main Results:

    • Beta-blockers competitively inhibit agonist binding to beta-adrenergic receptors.
    • They prevent arrhythmia promotion by beta-adrenergic stimulation without direct ion channel modification.
    • Effective in preventing sudden death in myocardial ischemia, long QT syndrome, and heart failure.
    • Valuable for ventricular rate control in atrial fibrillation.

    Conclusions:

    • Beta-blockers represent a unique class of antiarrhythmic agents.
    • Their mechanism involves modulating the effects of adrenergic stimulation on the heart.
    • They have established roles in preventing life-threatening arrhythmias and managing specific cardiac conditions.